Zhi Tian

Dr. Zhi Tian

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2023 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
XQXiaochen Qiao
Xiaochen Qiao
LYLei Yan
Lei Yan
YFYi Feng
Yi Feng
XLXiaoyan Li
Xiaoyan Li
KZKun Zhang
Kun Zhang
ZTZhi Tian
Zhi Tian
Objective: There are many injectable treatments for knee osteoarthritis with different characteristics and effects, the aim is to understand which one can lead to better and safer results. Methods: The PRISMA principles were followed when doing the literature search. Web of Science databases, Embase, the Cochrane Library, PubMed, and the Wanfang database were searched to identified randomized controlled trials that assessed the efficacy of corticosteroids (CSC), platelet-rich plasma (PRP), hyaluronic acid (HA), and combination therapy in treating KOA. Risk of bias was assessed using the relevant Cochrane tools (version 1.0). The outcome measure included the visual analog scale (VAS) score, the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) score, and treatment-related adverse events. The network meta-analysis was performed using STATA17 software and a Bayesian stratified random effects model. Results: Network meta-analysis using the Bayesian random-effects model revealed 35 studies with 3104 participants. PRP showed the best WOMAC score at a 3-month follow-up, followed by PRP + HA, HA, placebo, and CSC; PRP + HA scored the highest VAS, followed by PRP, CSC, HA, and placebo. PRP, CSC, HA, and placebo had the highest WOMAC scores six months following treatment; PRP + HA showed the best VAS scores. PRP showed the best WOMAC score at 12 months, followed by PRP + HA, HA, placebo, and CSC; The best VAS score was obtained with PRP, followed by PRP + HA, HA, and CSC. No therapy demonstrated a rise in adverse events linked to the treatment in terms of safety. Conclusions: The current study found that PRP and PRP + HA were the most successful in improving function and alleviating pain after 3, 6, and 12 months of follow-up. CSC, HA, PRP, and combination therapy did not result in an increase in the incidence of treatment-related side events as compared to placebo.

14 December 2022 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
XQXiaochen Qiao
Xiaochen Qiao
KZKun Zhang
Kun Zhang
XLXiaoyan Li
Xiaoyan Li
ZLZhi Lv
Zhi Lv
WWWenhao Wei
Wenhao Wei
ZTZhi Tian
Zhi Tian
Background: Assessing the correlation between gut microbiota (GM) and bone homeostasis has increasingly attracted research interest. Meanwhile, GM dysbiosis has been found to be associated with abnormal bone metabolism. However, the function of GM in disuse-induced osteoporosis (DIO) remains poorly understood. In our research, we evaluated the characteristics of GM and fecal metabolomics to explore their potential correlations with DIO pathogenesis.Methods: DIO rat models and controls (CON) underwent micro-CT, histological analyses, and three-point bending tests; subsequently, bone microstructures and strength were observed. ELISAs were applied for the measurement of the biochemical markers of bone turnover while GM abundance was observed using 16S rDNA sequencing. Metabolomic analyses were used to analyze alterations fecal metabolites. The potential correlations between GM, metabolites, and bone loss were then assessed.Results: In the DIO group, the abundance of GM was significantly altered compared to that in the CON group. Moreover, DIO significantly altered fecal metabolites. More specifically, an abnormally active pathway associated with bile acid metabolism, as well as differential bacterial genera related to bone/tissue volume (BV/TV), were identified. Lithocholic acid, which is the main secondary bile acid produced by intestinal bacteria, was then found to have a relationship with multiple differential bacterial genera. Alterations in the intestinal flora and metabolites in feces, therefore, may be responsible for DIO-induced bone loss.Conclusions: The results indicated that changes in the abundance of GM abundance and fecal metabolites were correlated with DIO-induced bone loss, which might provide new insights into the DIO pathogenesis. The detailed regulatory role of GM and metabolites in DIO-induced bone loss needs to be explored further.

26 January 2024 in Aging
Verified
Journal Article
Open access
PDF file
XQXiaochen Qiao
Xiaochen Qiao
XLXiaoyan Li
Xiaoyan Li
ZWZhichao Wang
Zhichao Wang
YFYi Feng
Yi Feng
XWXiaochun Wei
Xiaochun Wei
ZTZhi Tian
Zhi Tian
Background: The gut microbiota (GM) constitutes a critical factor in the maintenance of physiological homeostasis. Numerous studies have empirically demonstrated that the GM is closely associated with the onset and progression of osteoporosis (OP). Nevertheless, the characteristics of the GM and its metabolites related to different forms of OP are poorly understood. In the present study, we examined the changes in the GM and its metabolites associated with various types of OP as well as the correlations among them. Methods: We simultaneously established rat postmenopausal, disuse-induced, and glucocorticoid-induced OP models. We used micro-CT and histological analyses to observe bone microstructure, three-point bending tests to measure bone strength, and enzyme-linked immunosorbent assay (ELISA) to evaluate the biochemical markers of bone turnover in the three rat OP models and the control. We applied 16s rDNA to analyze GM abundance and employed untargeted metabolomics to identify fecal metabolites in all four treatment groups. We implemented multi-omics methods to explore the relationships among OP, the GM, and its metabolites. Results: The 16S rDNA sequencing revealed that both the abundance and alterations of the GM significantly differed among the OP groups. In the postmenopausal OP model, the bacterial genera g__Bacteroidetes_unclassified, g__Firmicutes_unclassified, and g__Eggerthella had changed. In the disuse-induced and glucocorticoid-induced OP models, g__Akkermansia and g__Rothia changed, respectively. Untargeted metabolomics disclosed that the GM-derived metabolites significantly differed among the OP types. However, a Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis showed that it was mainly metabolites implicated in lipid and amino acid metabolism that were altered in all cases. An association analysis indicated that the histidine metabolism intermediate 4-(β-acetylaminoethyl) imidazole was common to all OP forms and was strongly correlated with all bone metabolism-related bacterial genera. Hence, 4-(β-acetylaminoethyl) imidazole might play a vital role in OP onset and progression. Conclusions: The present work revealed the alterations in the GM and its metabolites that are associated with OP. It also disclosed the changes in the GM that are characteristic of each type of OP. Future research should endeavor to determine the causal and regulatory effects of the GM and the metabolites typical of each form of OP.

25 April 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
LYLei Yan
Lei Yan
RZRuhao Zhou
Ruhao Zhou
YFYi Feng
Yi Feng
RLRuoqi Li
Ruoqi Li
LZLong Zhang
Long Zhang
ZTZhi Tian
Zhi Tian
Micro RNAs (miRs) have been implicated in various tumorigenic processes. Osteosarcoma (OS) is a primary bone malignancy seen in adolescents. However, the mechanism of miRs in OS has not been fully demonstrated yet. Here, miR-134-5p was found to inhibit OS progression and was also expressed at significantly lower levels in OS tissues and cells relative to normal controls. miR-134-5p was found to reduce vasculogenic mimicry, proliferation, invasion, and migration of OS cells, with miR-134-5p knockdown having the opposite effects. Mechanistically, miR-134-5p inhibited expression of the ITGB1/MMP2/PI3K/Akt axis, thus reducing the malignant features of OS cells. In summary, miR-134-5p reduced OS tumorigenesis by modulation of the ITGB1/MMP2/PI3K/Akt axis, suggesting the potential for using miR-134-5p as a target for treating OS.

3 July 2024 in Aging
Verified
Journal Article
Open access
PDF file
YLYuan Li
Yuan Li
XQXiaochen Qiao
Xiaochen Qiao
YFYi Feng
Yi Feng
RZRuhao Zhou
Ruhao Zhou
KZKun Zhang
Kun Zhang
ZTZhi Tian
Zhi Tian
Previous studies have reported the correlation between gut microbiota (GM), GM-derived metabolites, and various intestinal and extra-intestinal cancers. However, limited studies have investigated the correlation between GM, GM-derived metabolites, and osteosarcoma (OS). This study successfully established a female BALB/c nude mouse model of OS. Mice (n = 14) were divided into the following two groups (n = 7/group): OS group named OG, injected with Saos-2 OS cells; normal control group named NCG, injected with Matrigel. The GM composition and metabolites were characterized using 16S rDNA sequencing and untargeted metabolomics, respectively. Bioinformatics analysis revealed that amino acid metabolism was dysregulated in OS. The abundances of bone metabolism-related genera Alloprevotella, Rikenellaceae_RC9_gut_group, and Muribaculum were correlated with amino acid metabolism, especially histidine metabolism. These findings suggest the correlation between GM, GM-derived metabolites, and OS pathogenesis. Clinical significance: The currently used standard therapeutic strategies for OS, including surgery, chemotherapy, and radiation, are not efficacious. The findings of this study provided novel insights for developing therapeutic, diagnostic, and prognostic strategies for OS.

3 September 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
ZHZhicheng He
Zhicheng He
SXSongrui Xu
Songrui Xu
NMNingning Ma
Ningning Ma
YZYin Zuo
Yin Zuo
XCXinyu Chen
Xinyu Chen
ZTZhi Tian
Zhi Tian
Objective: This study aims to visualize and analyze the literature on osteoarthritis (OA) and gut microbiota (GM) over the past decade (2011–2024) using bibliometric methods, and to understand the current research status and development trend in this field.Methods: Web of Science Core Collection was used as the source of literature, and the time limit was from January 2011 to July 2024, and the topics included “osteoarthritis” and “gut microbiota.” The included literature was analyzed in terms of annual distribution, country distribution, institutions, authors, keywords, and journals using Excel and CiteSpace.Results: A total of 192 articles were identified. Despite the limited volume, publication output demonstrated a consistent growth trend over the study period. Countries and institutions with the highest publication output and citation impact were predominantly located in China and the United States. The journals with the highest number of articles were mostly concentrated in Switzerland, and the research direction was mainly related to osteoarthritis and cartilage. The keywords appearing in the searched articles were gut microbiota, knee osteoarthritis, inflammation, rheumatoid arthritis, and gut microbiome.Conclusion: The research on OA and GM in China and abroad has shown an increasing trend, and the content of the research has been deepening with the passage of time. While the precise mechanisms remain elusive, targeting GM modulation emerges as a promising therapeutic strategy for OA, with potential clinical applications in disease prevention and management.